• Evaluating Global Early Market Access Opportunities For Innovative Therapies- Focus On Japan, Uk And Us

    May 1, 2015, 00:00

  • Health economic model to measure the impact of a stemi initiative in Romania

    May 1, 2015, 00:00

  • Impact of walking impairment on Healthcare resource utilisation in multiple sclerosis Patients

    May 1, 2015, 00:00

  • OUTCOMES AND HEALTH RESOURCE UTILIZATION AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT AN ACADEMIC MEDICAL CENTER (AMC) IN THE UNITED STATES

    May 1, 2015, 00:00

  • Treatment Costs for Uncomplicated Malaria at a Secondary Health Care Facility In Nigeria

    May 1, 2015, 00:00

  • Treatment for substance use and implications for Mortality in elderly prostate Cancer Patients

    May 1, 2015, 00:00

  • Resource Utilization and costs associated with off-label use of atypical Antipsychotics in a Community-Dwelling Adult Population- findings from the Medical Expenditure Survey

    May 1, 2015, 00:00

  • Cost-Utility Analysis of Apixaban In Patients With Atrial Fibrillation (Af) At The Peruvian Social Security (Essalud)

    May 1, 2015, 00:00

  • Patterns of Care In The Workup And Management of Non-Metastatic And Metastatic Colorectal Cancer

    May 1, 2015, 00:00

  • Quality of Life In Adult Patients with cystic Fibrosis €“ a Systematic Review

    May 1, 2015, 00:00

  • Estimating Quality of Life of Patients with Lipodystrophy

    May 1, 2015, 00:00

  • Assessment of Osteoporsis Knowledge And Perception Among Female University Students In Quetta, Pakistan

    May 1, 2015, 00:00

  • Who is spending where- analysis of Healthcare spending by Medicaid and Private Payers in Massachusetts

    May 1, 2015, 00:00

  • Cost-Effectiveness analysis and Budget Impact of an extended Versus Immediate release formulation of Metformin In Type-2 Diabetes mellitus Treatment, from the Perspective of The brazilian Public Health System

    May 1, 2015, 00:00

  • Derivation of A Preference-Based Measure for Metastatic Breast Cancer Using The Eortc Qlq-30 And Qlq-Br 23

    May 1, 2015, 00:00

  • Efficacy And Safety of Canagliflozin among Patients with type 2 diabetes Mellitus- a Systematic review and meta-analysis

    May 1, 2015, 00:00

  • Temporal Trend and Prevalence of Ckd Stages (Kdigo 2012) in Us Adults with Type 2 Diabetes Mellitus and demographic Subgroups- Nhanes 2007-2012

    May 1, 2015, 00:00

  • Pralatrexate Treatment In Patients With Relapsed Or Refractory Peripheral T-Cell Lymphoma- A Systematic Review And Meta-Analysis

    May 1, 2015, 00:00

  • Use of multiple concurrent Antipsychotics in Children enrolled in the Mississippi Medicaid Program

    May 1, 2015, 00:00

  • Comparison of real-world hypoglycemia rates among Patients Initiating Treatment with Saxagliptin or Glipizide

    May 1, 2015, 00:00

  • A Retrospective Analysis of the Economic Burden Among Patients Diagnosed with Chronic Migraine using the Veterans Health Administration Medical data

    May 1, 2015, 00:00

  • Long-term impact of a Pharmacist-Led Diabetes medication management program on Glycemic control

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination In Mainland China

    May 1, 2015, 00:00

  • Relationship between the development of Electronic Health records and Hospital accreditation decisions in Fran results from the E-SI (preps-sips) study

    May 1, 2015, 00:00

  • Once-Daily Single-tablet Regimen Reduce Loss to Follow-up In People Living With Hiv

    May 1, 2015, 00:00

  • Cost-Effectiveness Of Riociguat For Treatment Of Patients With Inoperable Or Post-Operative Recurrent/Persistent Chronic Thromboembolic Pulmonary Hypertension (Cteph) In Turkey

    May 1, 2015, 00:00

  • Uterine fibroid treatment patterns in the three years following Diagnosis

    May 1, 2015, 00:00

  • Epidemiology of advanced Therapies for the treatment of Diabetic foot ulcers in outpatient care settings

    May 1, 2015, 00:00

  • A Descriptive Analysis of Patient Characteristics, Bleeding And Recurrence Risk Among U.S Veteran Patients Diagnosed With Venous Thromboembolism

    May 1, 2015, 00:00

  • Colorectal Cancer (CRC) costs in the us- findings from the Medical Expenditure Panel Survey 2008-2012

    May 1, 2015, 00:00

  • Assessing the impact of varying threshold criteria for Opioid Overutilization

    May 1, 2015, 00:00

  • Perceptions of community Pharmacists about their current professional role, inter professional learning and continue professional development in Pakistan

    May 1, 2015, 00:00

  • Combining Mcda With Advanced Statistics To Tackle Challenges Of Data And Judgment Uncertainty- Case Study Of Safety Assessments

    May 1, 2015, 00:00

  • Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2- Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force

    Mar 1, 2015, 00:00

  • The Changing Face of the Cost-Utility Literature, 1990–2012

    Mar 1, 2015, 00:00

  • Editorial Board

    Mar 1, 2015, 00:00

  • Cost-Utility Analyses in Diabetes- A Systematic Review and Implications from Real-World Evidence

    Mar 1, 2015, 00:00

  • Potential Application of Machine Learning in Health Outcomes Research and Some Statistical Cautions

    Mar 1, 2015, 00:00

  • Strengthening Tuberculosis Control Overseas- Who Benefits?

    Mar 1, 2015, 00:00

  • Instructions for Authors

    Mar 1, 2015, 00:00

  • Copyright/Subscription

    Mar 1, 2015, 00:00

  • Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis

    Mar 1, 2015, 00:00

  • Clinical Trials Provide Essential Evidence, but Rarely Offer a Vehicle for Cost-Effectiveness Analysis

    Mar 1, 2015, 00:00

  • A Unified Framework for Classification of Methods for Benefit-Risk Assessment

    Mar 1, 2015, 00:00

  • Effect of Adherence and Insulin Delivery System on Clinical and Economic Outcomes among Patients with Type 2 Diabetes Initiating Insulin Treatment

    Mar 1, 2015, 00:00

  • Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Following First-Line Therapy in Patients with Follicular Lymphoma

    Mar 1, 2015, 00:00

  • Public Preferences for Prioritizing Preventive and Curative Health Care Interventions- A Discrete Choice Experiment

    Mar 1, 2015, 00:00

  • Fairness versus Efficiency of Vaccine Allocation Strategies

    Mar 1, 2015, 00:00

  • Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013

    Mar 1, 2015, 00:00

  • Erratum

    Mar 1, 2015, 00:00

  • Merging Regulatory and Reimbursement Needs in Clinical Trials

    Mar 1, 2015, 00:00

  • Application of Multicategory Exposure Marginal Structural Models to Investigate the Association between Long-Acting Beta-Agonists and Prescribing of Oral Corticosteroids for Asthma Exacerbations in the Clinical Practice Research Datalink

    Mar 1, 2015, 00:00

  • Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

    Mar 1, 2015, 00:00

  • Predictors of Self-Reported Adherence to Antihypertensive Medicines- A Multinational, Cross-Sectional Survey

    Mar 1, 2015, 00:00

  • Table of Contents

    Mar 1, 2015, 00:00

  • Dynamic Simulation in Health Care Comes of Age

    Mar 1, 2015, 00:00

  • A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part I- Descriptive Characteristics

    Mar 1, 2015, 00:00

  • Need for Multicriteria Evaluation of Generic Drug Policies

    Mar 1, 2015, 00:00

  • Mapping the Clinical Chronic Obstructive Pulmonary Disease Questionnaire onto Generic Preference-Based EQ-5D Values

    Mar 1, 2015, 00:00

  • Learning and Satisficing- An Analysis of Sequence Effects in Health Valuation

    Mar 1, 2015, 00:00

  • Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”- A Novel Measure for Cost-Containment of Drug Expenditure

    Mar 1, 2015, 00:00

  • Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes- A Comparison of Sample Size Requirements for an Incontinence Treatment Trial

    Mar 1, 2015, 00:00

  • A Systematic Review of Generic Multidimensional Patient-Reported Outcome Measures for Children, Part II- Evaluation of Psychometric Performance of English-Language Versions in a General Population

    Mar 1, 2015, 00:00

  • Critical Appraisal of Network Meta-Analyses Evaluating the Efficacy and Safety of New Oral Anticoagulants in Atrial Fibrillation Stroke Prevention Trials

    Mar 1, 2015, 00:00

  • Evaluation of Patient Registries Supporting Reimbursement Decisions- The Case of Oxaliplatin for Treatment of Stage III Colon Cancer

    Jan 1, 2015, 00:00

  • Optimizing the Leveraging of Real-World Data to Improve the Development and Use of Medicines

    Jan 1, 2015, 00:00

  • Physicians’ Preferences for Bone Metastases Drug Therapy in the United States

    Jan 1, 2015, 00:00

  • Network Meta-Analysis- Development of a Three-Level Hierarchical Modeling Approach Incorporating Dose-Related Constraints

    Jan 1, 2015, 00:00

  • Estimating Quality-Adjusted Life-Year Loss Due to Noncommunicable Diseases in Korean Adults through to the Year 2040

    Jan 1, 2015, 00:00

  • Pediatricians’ Preferences for Infant Meningococcal Vaccination

    Jan 1, 2015, 00:00

  • Erratum

    Jan 1, 2015, 00:00

  • An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5D

    Jan 1, 2015, 00:00

  • Code of Ethics

    Jan 1, 2015, 00:00

  • Copyright/Subscription

    Jan 1, 2015, 00:00

  • Using Classical Test Theory, Item Response Theory, and Rasch Measurement Theory to Evaluate Patient-Reported Outcome Measures- A Comparison of Worked Examples

    Jan 1, 2015, 00:00

  • Instructions for Authors

    Jan 1, 2015, 00:00

  • Editorial Board

    Jan 1, 2015, 00:00

  • Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?

    Jan 1, 2015, 00:00

  • Measuring Health-Related Quality of Life by Experiences- The Experience Sampling Method

    Jan 1, 2015, 00:00

  • High-Dose Hemodialysis versus Conventional In-Center Hemodialysis- A Cost-Utility Analysis from a UK Payer Perspective

    Jan 1, 2015, 00:00

  • Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”- A Novel Measure for Cost-Containment of Drug Expenditure

    Jan 1, 2015, 00:00

  • Risk Attitudes and Personality Traits Predict Perceptions of Benefits and Risks for Medicinal Products- A Field Study of European Medical Assessors

    Jan 1, 2015, 00:00

  • Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research—The SIMULATE Checklist- Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force

    Jan 1, 2015, 00:00

  • Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis

    Jan 1, 2015, 00:00

  • Comparing Measurement Properties of the EQ-5D-3L, ICECAP-O, and ASCOT in Frail Older Adults

    Jan 1, 2015, 00:00

  • Measuring Change in Quality of Life- Bias in Prospective and Retrospective Evaluation

    Jan 1, 2015, 00:00

  • Table of Contents

    Jan 1, 2015, 00:00

  • Cost-Effectiveness of Telaprevir in Patients with Genotype 1 Hepatitis C in Australia

    Dec 1, 2014, 00:00

  • ERRATUM

    Dec 1, 2014, 00:00

  • Table of Contents

    Dec 1, 2014, 00:00

  • Optimizing the Position and Use of Omalizumab for Severe Persistent Allergic Asthma Using Cost-Effectiveness Analysis

    Dec 1, 2014, 00:00

  • Predicting Adherence to Medications Using Health Psychology Theories- A Systematic Review of 20 Years of Empirical Research

    Dec 1, 2014, 00:00

  • Parents’ Willingness to Pay for Biologic Treatments in Juvenile Idiopathic Arthritis

    Dec 1, 2014, 00:00

  • Validation of the Patient Perception of Intensity of Urgency Scale in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia

    Dec 1, 2014, 00:00

  • Capitalizing on Prescribing Pattern Variation to Compare Medications for Type 2 Diabetes

    Dec 1, 2014, 00:00

  • Instructions for Authors

    Dec 1, 2014, 00:00

  • Copyright/Subscription

    Dec 1, 2014, 00:00

  • Conceptual Model and Economic Experiments to Explain Nonpersistence and Enable Mechanism Designs Fostering Behavioral Change

    Dec 1, 2014, 00:00

  • Cost-Effectiveness of Three Adjunct Cellular/Tissue-Derived Products Used in the Management of Chronic Venous Leg Ulcers

    Dec 1, 2014, 00:00

  • Mapping from the Health Assessment Questionnaire to the EQ-5D- The Impact of Different Algorithms on Cost-Effectiveness Results

    Dec 1, 2014, 00:00

  • Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort- Does the ADDITION Validation Add Up?

    Dec 1, 2014, 00:00

  • Valuations of Genetic Test Information for Treatable Conditions- The Case of Colorectal Cancer Screening

    Dec 1, 2014, 00:00

  • Editorial Board

    Dec 1, 2014, 00:00

  • US Valuation of Health Outcomes Measured Using the PROMIS-29

    Dec 1, 2014, 00:00

  • Evolution of Drug Reimbursement in Canada- The Pan-Canadian Pharmaceutical Alliance for New Drugs

    Dec 1, 2014, 00:00

  • Does Convenience Matter in Health Care Delivery? A Systematic Review of Convenience-Based Aspects of Process Utility

    Dec 1, 2014, 00:00

  • Toward a Functional Definition of a “Rare Disease” for Regulatory Authorities and Funding Agencies

    Dec 1, 2014, 00:00

  • Economic Evaluation of a Cluster Randomized Trial of Interventions to Improve Health Workers’ Practice in Diagnosing and Treating Uncomplicated Malaria in Cameroon

    Dec 1, 2014, 00:00

  • Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers

    Nov 1, 2014, 00:00

  • The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort)

    Nov 1, 2014, 00:00

  • Testing E-PRO Device Usability During the Translation Process- A Case Study of the Exact in 7 Countries

    Nov 1, 2014, 00:00

  • Burden of Atopic Dermatitis in Indonesia, Malaysia, and Singapore- Estimates from a Mathematical Model

    Nov 1, 2014, 00:00

  • Assessment of The Economic Value Of Dpp-4 Inhibitor Alogliptin Compared With Sitagliptin, Saxagliptin, And Linagliptin

    Nov 1, 2014, 00:00

  • Health Care Costs Associated With Cardiovascular Events In Patients With Hyperlipidemia - Estimates From Population-Based Register Data In Sweden

    Nov 1, 2014, 00:00

  • Predicting the Burden of Knee Arthroplasty Revision Over A 20-Year Horizon

    Nov 1, 2014, 00:00

  • What explains willingness to pay for avoiding morbidity risk due to malaria? Results from a global meta analysis

    Nov 1, 2014, 00:00

  • Determinants of Hospitals' Attractiveness For Patients- Application to Expensive Drugs

    Nov 1, 2014, 00:00

  • THE DEVELOPMENT AND PRELIMINARY VALIDATION OF THE MANCHESTER SLEEP SYMPTOMS INDEX (MSSI) FOR PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

    Nov 1, 2014, 00:00

  • Clinical Psychologists- Closing The Communication Gap Between Physicians And Patients, Leading To Higher Patient Satisfaction And Compliance

    Nov 1, 2014, 00:00

  • Novel Indirect Comparison Methodology for Estimating Time-Dependent Response To Antimuscarinics for the Treatment of Oab

    Nov 1, 2014, 00:00

  • Best Practices in Integrating Home Glucometer Measurements With Electronic Patient Reported Outcomes (Epro) In Clinical Trials

    Nov 1, 2014, 00:00

  • Hipos-Er (Hypoglycemia in Portugal Observational Study – Emergency Room)- Costs And Health Care Resource Consumption Data

    Nov 1, 2014, 00:00

  • Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As)

    Nov 1, 2014, 00:00

  • Cost savings for the use of antibacterial sutures in spanish hospitals. Budget impact model

    Nov 1, 2014, 00:00

  • Predictive Validity of Inappropriate Prescribing Criteria for Adverse Drug Events, Hospitalizations, and Emergency Department Visits- A Time-To-Event Comparison of the Beers and Stopp Criteria

    Nov 1, 2014, 00:00

  • Market Access and Reimbursement Options For Orphan Durg Hospital Only Medicines In Europe – One Size Fits All?

    Nov 1, 2014, 00:00

  • Retrospective analysis of the economic burden among cushing's disease patients in the u. S. Medicaid program

    Nov 1, 2014, 00:00

  • Risk-Sharing Schemes In Poland - Analysis And Classification of Rss Proposed In Reimbursement Application Received by Ahtapol In 2013

    Nov 1, 2014, 00:00

  • Health Care Utilization and Costs After Warfarin Discontinuation Among Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2014, 00:00

  • Clinical Trial Simulation Considering Quality Of Life Outcomes

    Nov 1, 2014, 00:00

  • Quadrivalent Influenza Vaccine in Hong Kong- a Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in Sweden

    Nov 1, 2014, 00:00

  • Comparative Effectiveness of An Acellular Synthetic Matrix As An Adjunct to Standard Care In The Treatment of Venous And Mixed Leg Ulcers- Modeling of Clinical Data And Routine Data

    Nov 1, 2014, 00:00

  • Association of Severity Assessment Tool with the Outcome of Organophosphorus Poisoning in Tertiary Care Teaching Hospital

    Nov 1, 2014, 00:00

  • Association of Colchicine with Primary and Secondary Cardiovascular Events in Peritoneal Dialysis Patients- A Propensity Score Analysis

    Nov 1, 2014, 00:00

  • Spending on HIV and AIDS in Indonesia- The Role of Government and Other Public Source of Fund to Maintain Quality and Equity

    Nov 1, 2014, 00:00

  • A comparative public health and budget impact analysis of pneumococcal vaccines. The french case

    Nov 1, 2014, 00:00

  • The Use of Patient Reported Outcomes (Pros) By the Pharmaceutical Industry in Japan – A Brief Review of Pmda Data in Comparison With Fda and Ema-Approved Label Claims

    Nov 1, 2014, 00:00

  • Economic Evaluation of Lacosamide in the Management of Epileptic Partial Onset Seizures in Greece

    Nov 1, 2014, 00:00

  • Economic Considerations On the Use of Mifamurtide In the Treatment of Osteosarcoma In Spain

    Nov 1, 2014, 00:00

  • Impact of Cost- Containment Policies on Biosimilars Market

    Nov 1, 2014, 00:00

  • Metabolic Disorders, Osteoporosis and Fracture Risk in Asia- A Systematic Review

    Nov 1, 2014, 00:00

  • Clinical Characteristics Among Hypertension Patients with Dislipidemia In Shanghai, China

    Nov 1, 2014, 00:00

  • Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Access To Orphan Drugs in Fran The Case Of Siklos For The Treatment of Sickle Cell Syndrome Before The Council of State

    Nov 1, 2014, 00:00

  • Potential Prescriber Mapping In Rural Location Of South India

    Nov 1, 2014, 00:00

  • Assessing The Cost Effectiveness Of An Anticoagulation Clinic In Comparison With The Usual Medical Clinic In Kuala Lumpur Hospital

    Nov 1, 2014, 00:00

  • Dabigatran Users With Non-Valvular Atrial Fibrillation in the Us- A Characterization of Dabigatran Initiators and Switchers

    Nov 1, 2014, 00:00

  • Real World Studies, Challenges, Needs and Trends from the Industry

    Nov 1, 2014, 00:00

  • Factors Affecting the Selection of Sore Throat Lozenge of Drugstore's Customer at Nakornpathom Municipality, Nakornpathom Province, Thailand

    Nov 1, 2014, 00:00

  • Phenomenon of Inappropriate Drug Manufacturing in China - Past and Present

    Nov 1, 2014, 00:00

  • Compliance to Hemoglobin A1c Testing Recommendations Following Initial Diabetes Diagnosis

    Nov 1, 2014, 00:00

  • Estimating the Direct Medical Cost, Length of Stay and Impact of Reimbursement Change on Health Care Associated Infections

    Nov 1, 2014, 00:00

  • Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

    Nov 1, 2014, 00:00

  • Nurses Verse Other Health Professionals Perceptions on Quality and Safety Culture Elements in Greek Hospitals

    Nov 1, 2014, 00:00

  • Estimating Survival Data from Published Kaplan-Meier Curves- a Comparison of Methods

    Nov 1, 2014, 00:00

  • Sustainable Health Care Systems- The Role of Therapeutic Value and Value Based Pricing

    Nov 1, 2014, 00:00

  • What Factors Are Associated With Vaccination Programme Success?

    Nov 1, 2014, 00:00

  • An Update on Clinical And Economic Evidence Requirements for Advanced-Therapy Medicinal Products in Europe

    Nov 1, 2014, 00:00

  • Application Of The Methods of Evidence Based Medicine for the Analysis of European Health Systems and Health Policy Approaches

    Nov 1, 2014, 00:00

  • Claims Database Analysis Of Patients With Chronic Hepatitis C In Japan

    Nov 1, 2014, 00:00

  • How is Current Pharmaceuticals Pricing Policy on Generics Performing in Turkey Regarding Price Erosion?

    Nov 1, 2014, 00:00

  • Validation of A Global Economic Model to Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment Using Kras Testing For Cetuximab Therapy In Metastatic Colorectal Cancer

    Nov 1, 2014, 00:00

  • Medical Expenditure for People With Diabetes in Urban Employee Basic Medical Insureance in Fujian

    Nov 1, 2014, 00:00

  • Economic Evaluation of Ulipristal Acetate for the Treatment of Patients With Moderate and Severe Symptoms of Uterine Fibroids in Romania

    Nov 1, 2014, 00:00

  • Cost Estimation of Hiv Infection in Gree Data from an Infectious Diseases Unit

    Nov 1, 2014, 00:00

  • The Effect of Bacterial Lysates on Patients with Recurrent Respiratory Tract Infections- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia

    Nov 1, 2014, 00:00

  • Beliefs About Medicines In An Urban Black Hypertension Population

    Nov 1, 2014, 00:00

  • Valuing Health in the Uae- An Investigation of the Feasibility and Cultural Appropriateness of Using the TTO and DCE Methods to Generate Health State Values

    Nov 1, 2014, 00:00

  • Cognitive Impairment and Health Related Quality of Life in Relapsing Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Re Introduction of the Ranking Task in Eq-5d Valuation. Improved Data Quality and Reduced Level of Inconsistencies?

    Nov 1, 2014, 00:00

  • The Cancer Drugs Fund- A Systematic Analysis of the Requirements For Inclusion on the English National List of Drugs for Priority Funding

    Nov 1, 2014, 00:00

  • Qualitative Equivalence Between A Paper and Electronic Tablet Version of the Womac®Nrs3.1 and Patient Global Assessment

    Nov 1, 2014, 00:00

  • Patient Count Projections for Advanced Melanoma by Line of Therapy and Other Clinical Characteristics in EU Countries- Results from The UK, Germany, France, Italy and Spain (EU-5)

    Nov 1, 2014, 00:00

  • Economic Burden of Eye Disease in Diabetic Patients- Literature Review

    Nov 1, 2014, 00:00

  • The Economic Impact Of Cardiovascular Events In Patients Post Myocardial Infarction- Uk Health Care Perspective

    Nov 1, 2014, 00:00

  • Burden of Illness of Dementia in China

    Nov 1, 2014, 00:00

  • Patient Preferences And Hiv Drugs- What About Uncertainty?

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes In Moderate To Severe Hemophilia Patients- Finding From A Cross-Sectionalstudy In Korea

    Nov 1, 2014, 00:00

  • Treatment of Mrsa Pneumonia- Economical and Clinical Comparison of Linezolid Verse Vancomycin

    Nov 1, 2014, 00:00

  • Cost Utility Analysis of Infliximab for the Treatment of Severe Rheumatoid Arthritis in Thailand

    Nov 1, 2014, 00:00

  • Quantifying Nonlinear Effects in Stochastic Markov Simulation Using UKPDS 68 and Ukpds 82 Equations in Type 2 Diabetes Modeling Analysis With the IMS Core Diabetes Model (CDM)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of a COPD Disease Management Program in Primary Care- The Recode Cluster Randomized Trial

    Nov 1, 2014, 00:00

  • Health Related Quality of Life of Patients and Their Caregivers In Rare Diseases Results of the Burqol-Rd Project In Hungary

    Nov 1, 2014, 00:00

  • Examining Opioid-Dependent Chronic Pain Patients Experiences On Buprenorphine Maintenance Therapy In The Texas Workers Compensation System- Pilot Study - Part 2

    Nov 1, 2014, 00:00

  • A Framework for the Economic Evaluation of Sequential Therapies for Chronic Conditions

    Nov 1, 2014, 00:00

  • Resource Utilisation in a Complex Treatment Regimen for Hepatitis C

    Nov 1, 2014, 00:00

  • Stress Load Factors in the Scope of Students

    Nov 1, 2014, 00:00

  • Functional Status, Quality of Life And Work Disability for Patients With Rheumatic Diseases in Greece

    Nov 1, 2014, 00:00

  • Impact Of Health Policy Changes on Unit Sales of 5 Top Selling Atc1 Phramaceutical Groups In Turkey

    Nov 1, 2014, 00:00

  • Understanding the Need and Value of Surrogate Endpoints for Health Care Decision Making in Asia Pacific

    Nov 1, 2014, 00:00

  • Effectiveness Of Probiotics In Irritable Bowel Syndrome- A Systematic Review With Meta-Analysis

    Nov 1, 2014, 00:00

  • Absenteeism and Presenteeism in A Population of Patients with Diabetic Foot Ulcers in Poland

    Nov 1, 2014, 00:00

  • The Impact of the German Drg-System on Policy Decision Making in Ent

    Nov 1, 2014, 00:00

  • Preferences for Prioritizing Patients with Rare Diseases- a Survey of the General Population in Sweden

    Nov 1, 2014, 00:00

  • Cost-Effectiveness-Analysis of The New-Born Screening in Austria

    Nov 1, 2014, 00:00

  • Comparative Safety and Efficacy of Focused Ultrasound for Cervical Ectopy- A Meta Analyses with 16180 Patients

    Nov 1, 2014, 00:00

  • Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation- Follow-Up Results Of The Prefer In Af Registry

    Nov 1, 2014, 00:00

  • Health Care Costs in Patients Treated with Ipilimumab for Advanced Melanoma Results of a Retrospective Chart Review

    Nov 1, 2014, 00:00

  • Economic Evaluation In Portugal – Establishment of The National Health Technology Assessment System (Sinats)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain

    Nov 1, 2014, 00:00

  • 5-Year Survival is not an Appropriate Indicator for Cancer Control in the Population- Revisiting the Issue Based on UK Data

    Nov 1, 2014, 00:00

  • Estimating the Costs of Drug Supply for Rare Diseases Patients In Russia

    Nov 1, 2014, 00:00

  • An Economic Model To Investigate The Budget Impact In Spain Of Onabotulinumtoxina To Manage Urinary Incontinence In Patients With Idiopathic Overactive Bladder

    Nov 1, 2014, 00:00

  • The Use of Clinical Data Repository for the Establishment of an Osteoporosis Registry in A Large Health Organization in Israel- Epidemiologic and Pharmaepidemiologic Findings

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis of A Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 65 and Over in Norway

    Nov 1, 2014, 00:00

  • Adverse Drug Reactions of Haart Therapy Among Hiv/Aids Patients Treated at Infectious Disease Clinic

    Nov 1, 2014, 00:00

  • Review of Patient-Reported Outcomes in Diabetic Macular Edema

    Nov 1, 2014, 00:00

  • The Relative Efficacy of Treatments in First-Line Management of Newly Diagnosed Chronic Myeloid Leukaemia- Systematic Literature Review and Indirect Comparison

    Nov 1, 2014, 00:00

  • The Economic Impact of Therapy Optimization in Chronic Obstructive Pulmonary Disease in Portugal

    Nov 1, 2014, 00:00

  • Decomposing Growth Of Diabetes Drug Expenditure In Korea

    Nov 1, 2014, 00:00

  • Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy- Impact Of Regionalization In Treatments And Guidelines

    Nov 1, 2014, 00:00

  • Asthma and Copd In Spain- Quality of Life and Health Consumption Resources

    Nov 1, 2014, 00:00

  • Assessing Factors Associated with Youth Substance Abuse in the us Using a Structural Equation Model

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Simulation of Colonography Versus Colonoscopy in Germany- Is Laxative-Free Colonography Cost-Effective?

    Nov 1, 2014, 00:00

  • Associations Between Crohn's Disease Severity And Specific Socio-Demographic, Quality-Of-Life And Coping Factors

    Nov 1, 2014, 00:00

  • Initiation of Oral Anticoagulant Drugs- Identification of Drivers of Prescribing of New Agents Versus Warfarin

    Nov 1, 2014, 00:00

  • Provincial Hospital Tendering in China- Evaluating The Impact on Price

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting

    Nov 1, 2014, 00:00

  • Barriers of Pharmaceutical Care in Community Pharmacies- Evidences From Emerging Counteries

    Nov 1, 2014, 00:00

  • Comparative Cost-Effectiveness Study of Modern Radiation Therapies in Hungary for Localized Prostate Cancer

    Nov 1, 2014, 00:00

  • How Do Individuals Complete The Choice Tasks In A Discrete Choice Experiment?

    Nov 1, 2014, 00:00

  • Public Expenditure On Authorised Orphan Drugs In the Czech Republic Between 2008 and 2013

    Nov 1, 2014, 00:00

  • Inverse Probability of Censoring Weighted Analysis to Adjust the Treatment Effect on Overall Survival for Subsequent Therapy- A Case Study in a Clinical Trial in Multiple Myeloma

    Nov 1, 2014, 00:00

  • Impact of Drug Policy on Improving Access to Medicines In Delhi

    Nov 1, 2014, 00:00

  • Conceptual Comprehensiveness of Anxiety Instruments in Chronic Obstructive Pulmonary Disease- Exploring the Potential for Confounding Somatic Items

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic

    Nov 1, 2014, 00:00

  • Publication Manual of Budget Impact Analysis (Bia) by the Department of Science and Technology of the Ministry of Health (Decit)

    Nov 1, 2014, 00:00

  • Time Limits Restriction in Germany

    Nov 1, 2014, 00:00

  • Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Integration of The New COA Taxonomy - The Clinro Example

    Nov 1, 2014, 00:00

  • Access To Orphan Drugs In Greece During Economic Crisis

    Nov 1, 2014, 00:00

  • Economic Burden of Drug use in Patients with Alzheimer's Disease at Phramongkutklao Hospisstal and Medical College, Thailand- A 5-Year Trend Analysis

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of Ivabradine In Heart Failure With Reduced Left Ventricular Ejection Fraction In Spain

    Nov 1, 2014, 00:00

  • Standard Costs for Health Economic Evaluations- An International Comparison

    Nov 1, 2014, 00:00

  • Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis With Certolizumab Pegol- 96-Week Patient-Reported Outcome Results Of The Rapid-Psa Study

    Nov 1, 2014, 00:00

  • The Effect of A Likely Overemphasis on Ficiency-Related Test Attributes on Acmg Recommendations and Access To Newborn Screening (Nbs)

    Nov 1, 2014, 00:00

  • Use of Medications in the Event of Job Loss

    Nov 1, 2014, 00:00

  • Factors Associated With Weight Gain and Hypoglycaemia and The Impact Upon Hospitalisation in Type 2 Diabetes Patients Managed With Metformin Plus Sulphonylurea

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn (Nph) In Patients With Type 1 Diabetes Mellitus In Spain

    Nov 1, 2014, 00:00

  • Impact of Assisted Reproductive Therapy (Art) On Infant Health and Health Care Cost Outcomes

    Nov 1, 2014, 00:00

  • Evaluation of the Effectiveness of Implementing an Antimicrobial Stewardship Program in a Medical Center in Taiwan

    Nov 1, 2014, 00:00

  • Clinical and Economic Outcomes of Memantine Used in Moderate or Severe Dementia Patients in China- Results from a Health Economic Model

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Fondaparinux Versus Enoxaparin in Non-St Elevation Acute Coronary Syndrome in Thailand

    Nov 1, 2014, 00:00

  • Evaluating The Effects Of Anti-Thyroid Drugs And Thyroidectomy In Patients Receiving Radioactive Iodine Therapy For Graves' Hyperthyroidism - A Retrospective Study From A University Teaching Hospital In South West, Nigeria

    Nov 1, 2014, 00:00

  • Health-Related Quality Of Life (Hrqol) Of Asian Patients With End-Stage Renal Disease (Esrd) In Singapore

    Nov 1, 2014, 00:00

  • Anti-Cancer Treatments in Elderly (≥75 Years Old) Patients- A Retrospective Analysis

    Nov 1, 2014, 00:00

  • Sqaros – Standardized Questionnaire to Assess the Reliability of Observational Studies

    Nov 1, 2014, 00:00

  • Health-Related Quality Of Life And Subjective Happiness Of Patients With Benign Prostatic Hyperplasia- First Results Of A Cross-Sectional Survey From Hungary

    Nov 1, 2014, 00:00

  • A Systematic Review and Network Meta-Analysis Assessing the Effectiveness and Tolerability of Gliptins and Sulfonylureas as Monotherapy in Patients with Type 2 Diabetes Mellitus If Metformin is not Considered Appropriate

    Nov 1, 2014, 00:00

  • Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment

    Nov 1, 2014, 00:00

  • Patient's Participation in Improvement of Health Related Outcomes- The Better Care Plan

    Nov 1, 2014, 00:00

  • Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation

    Nov 1, 2014, 00:00

  • Medication Adherence and Discontinuation Predicted by Disease Duration in Glaucoma Patients- Findings From A Cross-Sectional Study in Korea

    Nov 1, 2014, 00:00

  • The Impact of Unfamiliarity In Palliative Care Under Pharmacotherapeutic Aspect

    Nov 1, 2014, 00:00

  • Model Based Medicine- A Next Frontier in Health Care

    Nov 1, 2014, 00:00

  • China Critical Illness Insurance Policy - The Recent Developments and Prospects

    Nov 1, 2014, 00:00

  • Out With The Old – In With The New- Would New Social Preference Weights For Eq-5d Inevitably Require A Reappraisal of Previous Cost-Effectiveness Determinations?

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension – an Australian Payer Perspective

    Nov 1, 2014, 00:00

  • Updating Characteristics of Type 2 Diabetes Mellitus Patients in China- Surveys in year 2008 and 2011-12

    Nov 1, 2014, 00:00

  • Investigating the Knowledge of Pharmacists about Cosmetics Products in Pharmacies of Tehran (IRAN)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Fidaxomicin Therapy for Clostridium Difficile Infection in Hungary

    Nov 1, 2014, 00:00

  • Ethical Consideration on Methods of Health Research

    Nov 1, 2014, 00:00

  • Common Pregnancy Symptoms Increase the Risk Of Cardiovascular Disease

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Preventive Home Visits in Older Adults

    Nov 1, 2014, 00:00

  • Methodology For Selecting Expert Groups For The Purpose Of Decision-Making Tasks

    Nov 1, 2014, 00:00

  • Direct Cost of Diffuse Toxic Goiter and Its Complications In Ukraine

    Nov 1, 2014, 00:00

  • Orphan Drug Pricing In Fran Influence of Main Factors

    Nov 1, 2014, 00:00

  • Impact of Hpv-Vaccination- Health Gains for Female Population In Italy

    Nov 1, 2014, 00:00

  • Forecasting Cancer Incidence Using Gross Domestic Product

    Nov 1, 2014, 00:00

  • Evaluating the Quality of Evidence from a Network Meta-Analysis

    Nov 1, 2014, 00:00

  • Economic Burden of Chemotherapy Related Toxicities in Third Line Metastatic Breast Cancer Patients

    Nov 1, 2014, 00:00

  • Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients

    Nov 1, 2014, 00:00

  • The Role of Patients in Clinical Research and Evidence Based Decision Making as Reported Via A Survey of Patient Advocates

    Nov 1, 2014, 00:00

  • Cost-Minimisation Analysis of Colistimethate Sodium in Serbia- off Label Use Approach

    Nov 1, 2014, 00:00

  • Treatment Profile And Insulin Dose as a Factor Impacting Glycaemia Control Among Premix Insulin Users with T2DM in China

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Evaluation of Acute Exacerbation of Asthma in Patients in Malaysia

    Nov 1, 2014, 00:00

  • Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece

    Nov 1, 2014, 00:00

  • Modeling the Cost-Effectiveness of 100% Whey-Based Partially Hydrolyzed Versus. Cow's Milk Infant Formula in the Prevention of Atopic Dermatitis in Singapore

    Nov 1, 2014, 00:00

  • Patient Perspective- Pro Compliance and Effective Reminder Strategies

    Nov 1, 2014, 00:00

  • Using Modern Information Technology For Medical and Pharmaceutical Care Of Patients With Diabetes Mellitus In Ukraine

    Nov 1, 2014, 00:00

  • How Well the Pragmatic Randomized Controls in Joint Replacement Field- Results from Precis, Consort and Iom Tools' Assessment

    Nov 1, 2014, 00:00

  • Long-Term Impact of the Dutch Colorectal Cancer Screening Programme on Cancer Inciden Exploration of the Serrated Pathway

    Nov 1, 2014, 00:00

  • The Importance of Migration Assessments- Ecoa Translations and Linguistic Validation

    Nov 1, 2014, 00:00

  • Treatment Costs for Breast Cancer in Japan- Large Claim Database Analysis

    Nov 1, 2014, 00:00

  • Apoptosis and Oxidative Stress Induced By Exposure of Microwave Radiation In Rat Thymus- Modulatory Effect of Melatonin

    Nov 1, 2014, 00:00

  • Does the Current Recommended Target LDL Goal Improve Survival for Acute Coronary Syndrome Patients in Hong Kong?

    Nov 1, 2014, 00:00

  • Health State Utilities In Chronic Heart Failure In The Uk

    Nov 1, 2014, 00:00

  • Conditional Resolutions in the Amnog Early Benefit Assessment

    Nov 1, 2014, 00:00

  • Complications, costs And Resource Utilization in Real-World Complex Abdominal Wall Reconstruction Patients

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis Of Rosuvastatin Use In Patients With Hypercholesterolemia In The Health Care Of Belarus

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis for Total Knee Arthroplasty Telerehabilitation- Proof of Concept of A Decision Model

    Nov 1, 2014, 00:00

  • Measuring the Efficiency of Hungarian Hospitals by Data Envelopment Analysis

    Nov 1, 2014, 00:00

  • Anticipated Price Disclosure- Impact on Funding Decisions in Australia

    Nov 1, 2014, 00:00

  • Are Patients' Preferences Transferable Between Countries? A Cross-European Discrete-Choice Experiment to Elicit Patients' Preferences for Osteoporosis Drug Treatment

    Nov 1, 2014, 00:00

  • Example of Analysis Utilizing Real World Data- Medical Cost Reduction of Combination Drugs

    Nov 1, 2014, 00:00

  • Gender-Related Behaviors in Drug Consumption In Italy

    Nov 1, 2014, 00:00

  • Linking Health Care Administrative Databases And National Registry Data In Order To Monitor Icd Therapy In Italy

    Nov 1, 2014, 00:00

  • Factors Contributing to Quality of Life in Copd in South Korea

    Nov 1, 2014, 00:00

  • Comparison of Health Care Utilization and Costs for Patietns with Asthma by Severity and Health Insurance in Thailand- Using Generalized Linear Regression Model

    Nov 1, 2014, 00:00

  • Comparison of Treatment Patterns and Disease Severity Among Patients With Psoriatic Arthritis (Psa) Receiving Their First Biologic, Treated By Rheumatologists and Dermatologists In Europe (Eu)

    Nov 1, 2014, 00:00

  • Prescribing Anti-Depressants by Baseline Severity- Evidence Synthesis, Economic Model and Value of Information Analysis

    Nov 1, 2014, 00:00

  • Expedited Regulatory Review and Authorisation of Medicines and Their Subsequent Appraisal By Hta Agencies in the European Union

    Nov 1, 2014, 00:00

  • A Decision-Focused Mixed Treatment Comparison (MTC) of Alternative Dpp-4 Inhibitors (Dpp-4i's) Used in Combination With Metformin or a Sulfonylurea for the Treatment of Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2014, 00:00

  • Prevalence of Major Depressive Disorder in China

    Nov 1, 2014, 00:00

  • Translation and Validation of Kidney Disease and Quality of Life (Kdqol-Sftm 1.2) Instrument to Measure Health Related Quality of Life Of Indian Patients with Kidney Disease

    Nov 1, 2014, 00:00

  • Evaluation of Factors Affecting Sales of Prescription

    Nov 1, 2014, 00:00

  • Comparison of the Preference-Based EQ-5D and SF-6D Health Indices in Multiethnic Asian Patients with End-Stage Renal Disease (ESRD)

    Nov 1, 2014, 00:00

  • Direct Medical Costs for Inpatient Treatment of Chronic Renal Failure in Guangzhou, China

    Nov 1, 2014, 00:00

  • Quality of Life (Qol) With Psoriasis- Ethnography Study Evaluating the Impact of Psoriasis On Moderate To Severe Patients In Europe (Eu), From A Patient's Perspective

    Nov 1, 2014, 00:00

  • Social Costs of Different Procedures In Bariatric Surgery In Patients With Obesity-Related Comorbidities

    Nov 1, 2014, 00:00

  • Funding Integrated Health Care Services

    Nov 1, 2014, 00:00

  • Disease Burden in Brazil and Health Technology Assessment- A Retrospective of Ten Years of Supporting

    Nov 1, 2014, 00:00

  • Population Health- Mental Health of us Veterans by Benefits Enrollment Status

    Nov 1, 2014, 00:00

  • Reimbursement Hurdles For High-Cost Brand-On-Brand Combinations and Impact on Patient Access

    Nov 1, 2014, 00:00

  • Build Model with Asia Pacific Region in Mind- Modeling INR Control in a Cost-Effectiveness Model for Stroke Prevention in Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Health Economics Methodologies Involving Parkinson's Disease Treatment in China

    Nov 1, 2014, 00:00

  • The Impact of the Information System of Medical Devices in Portugal

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Rivaroxaban In The Treatment Of Acute Venous Thromboembolism In The Uk

    Nov 1, 2014, 00:00

  • A Retrospective Study Of Mortality In Risk Patients With High Dose Statin Usage And No Statin Usage

    Nov 1, 2014, 00:00

  • Cdad-Daysyms™- A New Patient-Reported Outcome Tool For Clostridium Difficile-Associated Diarrhoea

    Nov 1, 2014, 00:00

  • Feasibility of A Network Meta-Analysis in Endometriosis

    Nov 1, 2014, 00:00

  • An Evaluation Of Medication Adherence In Hypertensive Patients Using The Theory Of Planned Behavior

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analyses of Screening and Treatment Strategies for Postmenopausal Osteoporosis in Chinese Women

    Nov 1, 2014, 00:00

  • Comparing Actual Patient Level Hospital Costs To The Canadian Cmg+ Costing Estimates For Acute Myocardial Infarction

    Nov 1, 2014, 00:00

  • Epidemiology and Severity of Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis of Antifungal Drug Use in the Intensive Care Unit

    Nov 1, 2014, 00:00

  • Cost of Cirrhosis among Patients Diagnosed with Hepatitis C Virus in Turkey

    Nov 1, 2014, 00:00

  • Cost-Minimization and Budget-Impact Analysis of Fixed-Dose ICS/LABA Combination Inhalers in the Treatment of Asthma in Slovenia

    Nov 1, 2014, 00:00

  • Psychometric Evaluation Of The Patient's Knee Implant Performance (PKIP) Questionnaire For The Assessment Of Primary Total Knee Arthroplasty

    Nov 1, 2014, 00:00

  • A Qualitative Exploration Of Malaysian Doctors' Perceptions Towards Complementary And Alternative Medicines (Cam)

    Nov 1, 2014, 00:00

  • Costs of Pneumonia in Patients With Cancer Diagnosis from the Private Health System Perspective in Brazil

    Nov 1, 2014, 00:00

  • Chronic Hepatitis C Prevalence and its Correlation with CD4 Cells and Liver Enzymes Among HIV Positive Patients- A Malaysian Scenario

    Nov 1, 2014, 00:00

  • Patient Reported Outcomes(Pros) in Patients with Lower Urinary Track Symptom(Luts)/Benign Prostatic Hyperplasia(Bph) Accompanied with Overactive Bladder(Oab) in Korea

    Nov 1, 2014, 00:00

  • Pharmacological Regimens for Eradication of Helicobacter Pylori- An Overview of Systematic Reviews and Network Meta-Analysis

    Nov 1, 2014, 00:00

  • Extrapolation of Trial-Based Survival Curves Using External Information

    Nov 1, 2014, 00:00

  • Transformation of Green Card Program for the Poor- One Step Further to Universal Health Care Coverage in Turkey

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Denosumab vs. Brand or Generic zoledronic Acid in Patients with Breast Cancer in Kazakhstan

    Nov 1, 2014, 00:00

  • Do Nice Decisions Affect Decisions in Other Countries?

    Nov 1, 2014, 00:00

  • Evaluating Prevalence of Self-Medication in Bahawalpur

    Nov 1, 2014, 00:00

  • Economic orphans? the prevalence of child-specific utilities in nice appraisals for paediatric indications

    Nov 1, 2014, 00:00

  • The Simultaneous Effects of Pharmaceutical Policies from Payers' and Patients' Perspectives. Italy as a Case Study

    Nov 1, 2014, 00:00

  • Cervical Assessment With Progesterone in the Prevention of Preterm Birth- A Strategy Based On Cost-Effectiveness

    Nov 1, 2014, 00:00

  • Reimbursement of Targeted Cancer Therapies Within Three Different European Health Care Systems

    Nov 1, 2014, 00:00

  • Drug Repurposing as An Efficient Strategy In Drug Development – Example Of Cns Area

    Nov 1, 2014, 00:00

  • A Validated Prediction Model and Nomogram for Risk of Recurrence in Early Breast Cancer Patients

    Nov 1, 2014, 00:00

  • Positron Emission Tomography/Computed Tomography Imaging for Non-Small Cell Lung Cancer- A Budget Impact Analysis

    Nov 1, 2014, 00:00

  • The Clinical Impact Of Rivaroxaban To Chinese At Deep Vein Thrombosis Patients Results From A Simple Communication Tool

    Nov 1, 2014, 00:00

  • The Prevalence of Tobacco Smoking in Patients With Diabetes in Hospital Pulau Pinang, Malaysia

    Nov 1, 2014, 00:00

  • Comparison Of The Burden Of Ibs With Constipation On Health-Related Quality Of Life (Hrqol), Work Productivity, And Health Care Utilization To Asthma, Migraine, And Rheumatoid Arthritis In The Us, Uk, And France

    Nov 1, 2014, 00:00

  • Assessing the Methodological Value of Digital Real-Time Collection of Qualitative Content in Supporting In-Depth Qualitative Interviews Exploring the Symptoms and Impacts of Gout on Health-Related Quality of Life

    Nov 1, 2014, 00:00

  • Management Of Chronic Thromboembolic Pulmonary Hypertension- Clinical And Reported Outcomes From A Referral Hospital In Spain

    Nov 1, 2014, 00:00

  • Benchmarking the Impact of HTA on New Medicines Development and Coverage Decision Making

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

    Nov 1, 2014, 00:00

  • Is Obesity A Problem In Brazil?

    Nov 1, 2014, 00:00

  • Effectiveness, Safety and Patients' Subjective Feelings of Insulin Pen-Needle- A Systematic Review

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Model of Pertuzumab in Combination with Trastuzumab and Docetaxel Compared with Trastuzumab in Combination with Docetaxel for the 1st Line Treatment of HER2+ Metastatic Breast Cancer in Colombia

    Nov 1, 2014, 00:00

  • Segmentation Is A Key Strategic Tool For Effective Prioritisation And Targeting Of Payers In Highly Competitive Markets; A Client's Perspective

    Nov 1, 2014, 00:00

  • Integrating Health Psychometrics With Health Economics- Can the ‘Mapping' Toolbox Be Extended Using Ordinal Structural Equation Models?

    Nov 1, 2014, 00:00

  • Investigating the Impact of Perspective on Weighting Qalys- a Discrete Choice Experiment

    Nov 1, 2014, 00:00

  • The Quality of Prescribing for Psychiatric Patients

    Nov 1, 2014, 00:00

  • Estimating Health Care Resource Utilization of Patients with Rheumatoid Arthritis in Taiwan Using a National Claims Database

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of A Medication Review With Follow-Up for Older People With Polypharmacy in Community Pharmacies in Spain- Consigue Program

    Nov 1, 2014, 00:00

  • Prescribing Pattern of Anti-Emetics for Prevention of Chemotherapy Induced Nausea Vomiting—An Observation of Clinical Practice Versus Standard Guidelines

    Nov 1, 2014, 00:00

  • Predicting the Impact of Value-Based Assessment on Future Nice Appraisals

    Nov 1, 2014, 00:00

  • Systematic Review and Meta-Analysis of Persistence With Denosumab in Patients With Osteoporosis

    Nov 1, 2014, 00:00

  • Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder- Early Experience In Canada

    Nov 1, 2014, 00:00

  • Medical Expenditure For People With Diabetes In Urban Employee Basic Medical Insurance For Hebei Provincial Institutes

    Nov 1, 2014, 00:00

  • Health Technology Assessment In Japan- History, Current Situation, and the Way Forward

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of Linaclotide- A Valuable Option In The Treatment Of Irritable Bowel Syndrome

    Nov 1, 2014, 00:00

  • Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in Ireland

    Nov 1, 2014, 00:00

  • Comparison of the Valuation of Treatment Alternatives in Parkinson's Disease with Best-Worst Scaling, Time Trade-off and Visual Analogue Scales

    Nov 1, 2014, 00:00

  • The Cost Burden Of Syncope At A Hospital Level In Spain

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Belimumab In the Treatment of Patients With Systemic Lupus Erythematosus In Russian Federation

    Nov 1, 2014, 00:00

  • Paliperidone Versus Atypical Long-Acting Antipsychotics for Relapsed Chronic Schizophrenia- an Economic Analysis

    Nov 1, 2014, 00:00

  • A Comparison of Value for Health States Worse Than Dead Between Japan and Uk

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the Application of Ertapenem for the Treatment of Community-Acquired Complicated Intra-Abdominal Infections

    Nov 1, 2014, 00:00

  • Understanding Real Life Treatment Patterns Among Patients With Hypertension- A Markov Model

    Nov 1, 2014, 00:00

  • Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries

    Nov 1, 2014, 00:00

  • Type 2 Diabetes Treatment Patterns Across Europe

    Nov 1, 2014, 00:00

  • Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study

    Nov 1, 2014, 00:00

  • Quality of Life in Psoriatic Arthritis- Consistent and Stable Across Datasets

    Nov 1, 2014, 00:00

  • Be Cautious Of Triple Whammy!!!

    Nov 1, 2014, 00:00

  • Early Retirement Indirect Costs Attributable to Rheumatic Diseases in Portugal

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Various Strategies For Antiviral Therapy For Previously Treated Patients With Chronic Hcv Genotipe 1 Infection

    Nov 1, 2014, 00:00

  • Direct Treatment Costs Of Cirrhosis In The Brazilian Public Health Care System- A 2008-2012 Retrospecteve Analysis

    Nov 1, 2014, 00:00

  • Suitability research on the Evaluation of EQ-5Q and SF-6D Scale for the Quality of Life in Patients with Osteoarthritis

    Nov 1, 2014, 00:00

  • COST-EFFECTIVENESS OF POST-THERAPY PET AND TELEPHONE INTERVIEW IN THE CLINICAL FOLLOW-UP OF PATIENTS TREATED WITH LOCALLY ADVANCED CERVICAL CANCER

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Targeted Pharmacotherapy – A Systematic Review of the Literature

    Nov 1, 2014, 00:00

  • Health Related Quality of Life in Patients Receiving Home Enteral Nutrition in Spain Assessed By A Specific Questionnaire- Nutriqol®

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Aflibercept in yhe Treatment of Metastatic Colorectal Cancer (MCRC) in Poland

    Nov 1, 2014, 00:00

  • The Effect of China's Basic Medical Insurance Schemes on Health Service Utilization

    Nov 1, 2014, 00:00

  • Comparing the Event Prediction Capability of the Ukpds68 and Hong Kong Diabetes Risk Equations within A Type 2 Diabetes Simulation Model

    Nov 1, 2014, 00:00

  • The Decision Making Process In Receiving Bone Conduction Implants (Bci) For Single Sided Deafness

    Nov 1, 2014, 00:00

  • Ahmed Abouzid

    Nov 1, 2014, 00:00

  • Determinants of Increasing the Likelihood for a Positive Drug Reimbursement Recommendation in Scotland

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Telaprevir Triple Therapy in Treatment-Experienced Chronic Hepatitis C Patients in Turkey

    Nov 1, 2014, 00:00

  • Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That is Refractory to Radioactive Iodine (RAI) Treatment

    Nov 1, 2014, 00:00

  • Evidence Resulting From Chart Review Methodology Applied To Named Patient Programme Participation And Compassionate Medication Use- Peri-Approval Approximation Of Post-Market Practice Patterns And Costs

    Nov 1, 2014, 00:00

  • The Efficiency Evaluation of the Rule From Drug Market Regulation Chamber (Cmed) Proposed To Public Medicines Acquisitions in Antitrust Market Conditions

    Nov 1, 2014, 00:00
  • «
  • 91
  • 92
  • 93 (current)
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »